Axsome Therapeutics (AXSM) Net profit US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
Net profit, bln rub ? -105.4 -134.9 -187.1 -197.8 -239.2   -311.0  
Changes by years, y/y, % +51% +28% +39% +6% +21%     +50.5%

Axsome Therapeutics. Net profit US GAAP, bln rub

Created with Highcharts 6.0.6-2.2-2.2-6.0-6.0-10.6-10.6-27.2-27.2-28.9-28.9-31.0-31.0-69.7-69.7-105.4-105.4-134.9-134.9-187.1-187.1-197.8-197.8-239.2-239.2-311.0-311.0201320142015201620172018201920202021202220222023LTM-350-300-250-200-150-100-500smart-lab.ru

Axsome Therapeutics. Net profit US GAAP, changes, %

Created with Highcharts 6.0.6177.0177.076.076.0157.6157.66.46.47.07.0125.0125.051.251.228.028.038.738.75.75.721.021.030.030.020142015201620172018201920202021202220222023LTM050100150200smart-lab.ru

Axsome Therapeutics. Net profit US GAAP, sum by quarters, bln rub

Created with Highcharts 6.0.6-1.5-1.5-1.7-1.7-7.3-7.3-7.4-7.4-9.6-9.6-24.8-24.8-29.2-29.2-35.3-35.3-61.2-61.2-66.8-66.8-98.7-98.7-4.6-4.6-7.2-7.2-6.4-6.4-8.3-8.3-19.1-19.1-22.9-22.9-34.9-34.9-47.2-47.2-62.2-62.2-64.6-64.6-2.1-2.1-6.8-6.8-7.1-7.1-8.3-8.3-13.8-13.8-18.3-18.3-32.3-32.3-41.4-41.4-42.8-42.8-67.2-67.2-79.3-79.3-5.9-5.9-8.0-8.0-4.8-4.8-10.6-10.6-32.5-32.5-29.3-29.3-41.0-41.0-11.2-11.2-68.4-68.44 quarter3 quarter2 quarter1 quarter2014201520162017201820192020202120222023202411-350-300-250-200-150-100-500smart-lab.ru

Axsome Therapeutics (AXSM) Net profit US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Net profit, bln rub ? -62.2 -98.7 -68.4 -79.3 -64.6   -311.0
Changes by years, y/y, % +32% +48% +509% +18% +4%    
Changes by quarters, q/q, % -7% +59% -31% +16% -19%    

Axsome Therapeutics. Net profit US GAAP, bln rub

Created with Highcharts 6.0.6-1.5-1.5-2.1-2.1-4.6-4.6-1.7-1.7-5.9-5.9-6.8-6.8-7.2-7.2-7.3-7.3-8.0-8.0-7.1-7.1-6.4-6.4-7.4-7.4-4.8-4.8-8.3-8.3-8.3-8.3-9.6-9.6-10.6-10.6-13.8-13.8-19.1-19.1-24.8-24.8-32.5-32.5-18.3-18.3-22.9-22.9-29.2-29.2-29.3-29.3-32.3-32.3-34.9-34.9-35.3-35.3-41.0-41.0-41.4-41.4-42.8-42.8-47.2-47.2-61.2-61.2-66.8-66.8-11.2-11.2-67.2-67.2-62.2-62.2-98.7-98.7-68.4-68.4-79.3-79.3-64.6-64.62014Q42015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-1000-125-75-50-25smart-lab.ru

Axsome Therapeutics. Net profit US GAAP, changes, y/y, %

Created with Highcharts 6.0.615.115.1219.9219.957.257.2327.6327.636.336.34.04.0-10.6-10.61.41.4-39.9-39.916.916.928.728.729.229.2121.4121.466.266.2131.1131.1158.5158.5205.3205.333.233.219.819.817.617.6-9.9-9.976.276.252.252.221.221.240.040.028.428.432.732.735.435.473.373.388.988.9-72.6-72.656.856.831.731.747.847.8509.4509.418.118.13.93.92015Q42016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-200-1000100200300400500600smart-lab.ru

Axsome Therapeutics. Net profit US GAAP, changes, q/q, %

Created with Highcharts 6.0.643.043.0114.9114.9-62.5-62.5242.3242.316.116.15.65.61.91.99.19.1-11.4-11.4-9.2-9.215.515.5-35.3-35.372.372.30.00.015.915.910.910.929.329.339.039.029.629.630.930.9-43.6-43.625.125.127.227.20.30.310.310.38.08.01.31.315.915.91.11.13.43.410.310.329.729.79.09.0-83.2-83.2498.8498.8-7.4-7.458.658.6-30.7-30.716.116.1-18.6-18.62015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-200-1000100200300400500600smart-lab.ru